Imara Announces Pricing of Public Offering
BOSTON, July 13, 2021 (GLOBE NEWSWIRE) — Imara Inc. (the “Company”) (Nasdaq: IMRA), a clinical-stage…
Month: July 2021
Celldex Therapeutics Announces Pricing of Upsized $250 Million Public Offering of Common Stock
HAMPTON, N.J., July 13, 2021 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (“Celldex” or the “Company”)…
Madrigal Pharmaceuticals Offers Patients Resmetirom in a Planned Open Label Active Treatment Extension of the Phase 3 MAESTRO-NAFLD-1 Clinical Study
CONSHOHOCKEN, Pa., July 13, 2021 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) announced today its…
scPharmaceuticals Inc. Announces Positive Top-Line Results from FREEDOM-HF Study
Reduced average 30-day heart failure related costs by $17,753 (p<0.0001) per study subject in FUROSCIX®…
Berkeley Lights to Report Second Quarter 2021 Financial Results on August 11, 2021
EMERYVILLE, Calif., July 13, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader…
Seer to Report Second Quarter Financial Results on August 12, 2021
REDWOOD CITY, Calif., July 13, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life…
Zealand Pharma A/S – Transaction Under Share Repurchase Program
Company announcement – No. 46 / 2021 Zealand Pharma A/S – Transaction Under Share Repurchase…
Imara Announces Launch of Proposed Public Offering
BOSTON, July 13, 2021 (GLOBE NEWSWIRE) — Imara Inc. (the “Company”) (Nasdaq: IMRA), a clinical-stage…
Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
Initiated Phase 1 trial of lead program NX-2127 in patients with relapsed or refractory B-cell…
CBD Trailblazer Turns CBD Users Into Investors
Nordic Oil, a market leader in the European CBD industry, has launched its first ever…
Groundbreaking Study Establishes Non-Surgical Treatment Modality to Improve Function in Children With Cerebral Palsy
SpineX’s Proprietary SCONE™ Device Offers New Hope to Families of Children with CP SCONE Device…
ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function Against Tumor Cells
ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function…
Infant Bacterial Therapeutics AB appoints Marie-Louise Alamaa as new CFO
Infant Bacterial Therapeutics AB (publ) today announced that Marie-Louise Alamaa has been appointed Chief Financial…
Lixte Biotechnology Comments on Outside Research Citing LB-100’s PP2A Inhibition as a Potential Therapeutic Strategy for Triple-Negative Breast Cancer
Altadena, CA, July 13, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) (“Lixte”…
Ocuphire Selected to Present at Multiple Ophthalmic Conferences in July
Positive Results from Phase 2 Presbyopia (VEGA-1) and Phase 3 Reversal of Mydriasis (MIRA-2) Studies…
Yield10 Bioscience Begins 2021 Field Test and Seed Scale Up Program
WOBURN, Mass., July 13, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural…
Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide
OSTEOAMP SELECT Flowable from Bioventus A demonstration of how OSTEOAMP SELECT Flowable can be easily…
Vallon Pharmaceuticals Announces Issuance of New European Patent Covering Method of Use and Composition of Matter for ADAIR
– Patent bolsters intellectual property protection as Company’s partner, MEDICE, works to develop and potentially…
ExCellThera and Astellas enter into a license for the use of molecule UM171 in the field of pluripotent stem cells
MONTREAL, July 13, 2021 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a clinical-stage molecular medicine company…
TFF Pharmaceuticals Announces Completion of Enrollment and Preliminary Data from its Phase 1 Clinical Trial of Tacrolimus Inhalation Powder
Inhaled Tacrolimus Powder Achieves Systemic Therapeutic Drug Levels Anticipate Additional Safety Data in 3Q 2021 Initiation of…